Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Aptevo Therapeutics Inc. (APVO) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Aptevo Therapeutics Inc. (APVO), most recent 12 months reported: net loss $28.08M. Latest balance sheet on file: liquid cash $9.8M. From SEC filings. Others in Pharmaceutical Preparations: AN2 Therapeutics, Inc. · Annovis Bio, Inc. · Aprea Therapeutics, Inc. · APIMEDS PHARMACEUTICALS US, INC. · ARTELO BIOSCIENCES, INC. · ATOSSA THERAPEUTICS, INC. · ARRIVENT BIOPHARMA, INC. · Atea Pharmaceuticals, Inc.

Stock screener

Watchlist